Evidence map›Paper›PMID 37496043›Full record

ArticleReproductive biology and endocrinology : RB&E2023

Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis.

Christos A Venetis, Christoph Helwig, Ben W Mol, Su Jen Chua, Salvatore Longobardi, Raoul Orvieto, Monica Lispi, Ashleigh Storr, Thomas D'Hooghe

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Christos A VenetisUnit for Human Reproduction, 1st Dept of OB/Gyn, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Christoph HelwigGlobal Biostatistics, Merck KGaA, Darmstadt, Germany.
Ben W MolDepartment of Obstetrics and Gynecology, University of Monash, Monash, Clayton, Victoria, 3168, Australia. ben.mol@monash.edu.
Su Jen ChuaAlfred Health, Melbourne, VIC, 3004, Australia.
Salvatore LongobardiGlobal Clinical Development, Merck Serono S.p.A (an affiliate of Merck KGaA, Darmstadt 64293, Germany), Rome, 00176, Italy.
Raoul OrvietoDepartment of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, 52621, Israel.
Monica LispiUniversity of Modena and Reggio Emilia, Modena, MO, 41121, Italy.
Ashleigh StorrFlinders Fertility, Adelaide, South Australia, 5045, Australia.
Thomas D'HoogheGlobalMedical Affairs Fertility, Research and Development, Merck KGaA, F135/002, Darmstadt, 64293, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37496043
PMCPMC10369731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.